-
-
-
-
-
-
-
Longeveron (LGVN) Completes Enrollment of Pivotal Phase 2b Trial of Laromestrocel
-
-
-
-
-
-
-
Form S-1/A Longeveron Inc.
-
-
-
-
-
-
-
Longeveron (LGVN) CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at AAIC
-
-
-
-
-
-
-
Form S-1 Longeveron Inc.
-
-
-
-
-
-
-
Longeveron Inc. Provides Corporate Update and Reports Second Quarter 2022 Financial Results
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Live Ventures, Generac, Longeveron, and AppHarvest and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Form S-1/A LONGEVERON LLC
-
64,524 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

